Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Business Strategies

People Briefs: NuVasive, Delcath, Boston Scientific, Silk Road, Si-Bone

This article was originally published in The Gray Sheet

  • News

Executive Summary

NuVasive and Delcath Systems appoint CEOs. Boston Scientific Corp. names senior medical director, rhythm management. Silk Road Medical Inc. appoints executive VP, global sales. Si-Bone taps CFO.

You may also be interested in...



People Briefs

Cohera Medical CEO named AdvaMed Accel chair; Trovagene sacks CEO and CFO over precision medicine dispute; OraSure Technologies appoints Eamonn Hobbs to board; DNA Diagnostics Center names its president and CEO; Lantheus Holdings taps CFO; Omcron gets new president and CEO.

New Product Briefs

Product news from Silk Road Medical, EnteroMedics, St. Jude, Tandem Diabetes and Abbott.

Next Steps For NuVasive Following CEO Resignation

The resignation of CEO Alex Lukianov could signal a shift in the spine firm's approach to sales and profitability that could ultimately make NuVasive as a more attractive acquisition candidate.

Table

View full table

Related Content

Medtech Insight

Topics

Tags:
Medical Device Business Strategies
Latest Headlines

Second EU MDR Notified Body Designated In France

Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217

CDS Final Guidance Draws More Criticism, This Time From Congress

Alarming Rise Of Diabetes in Several US States, Study Shows

See All
UsernamePublicRestriction

Register

MT033935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By